As Head of the Corporate and International Department, Dmitry has conducted over 100 M&A transactions, including deals with foreign and national investors. From 2010, healthcare became a primary sector for the Corporate and International Department. Specifically, Dmitry’s team has successfully completed complex M&A pharmaceutical transactions for foreign investors and protected clients from further hostile actions from sellers.
Currently, Dmitry is Corporate Legal Advisor for several Russian and international pharmaceutical and medical device companies such as VMG Pharmaceuticals Pvt. (India), Aquarius Enterprises, India (India), Aurobindo Pharma Limited (India), Ruseuropharm (Russia), Rezlov CJSC (Russian distributor of Plethico Pharmaceuticals Ltd), Delta Medical (Russia), Articon (Russia/CIS), Asclepius Meditec Co., Ltd (China), Pharmasintez (Russia).